Clinical Trial

Home Transcutaneous Electrical Acustimulation (TEA)

Study acronym: Home-TEA
Recruiting Phase 2/3
View on ClinicalTrials.gov →
Summary
This study will assess the efficacy of two active treatments with TEA and a chemical neuromodulator (escitalopram aka Lexapro) versus a sham comparator or control group on abdominal pain.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-08-24; most recent amendment 2025-10-09.
Status change: Not Yet Recruiting → Recruiting 2022-12-02
Trial Details
NCT Number NCT05519683
Lead Sponsor University of Michigan
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), National Center for Complementary and Integrative Health (NCCIH)
Conditions Irritable Bowel Syndrome With Constipation
Enrollment 160 participants
Start Date 2022-11-02
Primary Completion 2026-09 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-10-14